O'Neill Vincent

See Remarks | Chief Medical Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+38.5%

Avg 12M Return

+82.6%

O'Neill Vincent is a See Remarks at BioXcel Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.

Estimated insider holdings value: $24K based on current market prices.

Holdings by Company

BTAIDec 16, 2024

Current Shares20.0K

Value$23.6K

Net Activity-111,737

Bought: 0Sold: 111.7K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 16, 2024	BTAI Bioxcel Therapeutics, Inc.	See Remarks	Sale+OE	165	$0.35	$58.13	-0.8%	-64.9%	-71.1%
Oct 3, 2024	BTAI Bioxcel Therapeutics, Inc.	See Remarks	Sell	5,556	$0.55	$3,055.80	-22.1%	-28.7%	-71.3%
Sep 16, 2024	BTAI Bioxcel Therapeutics, Inc.	See Remarks	Sale+OE	138	$0.69	$95.33	-3.4%	-36.5%	-70.8%
Jun 17, 2024	BTAI Bioxcel Therapeutics, Inc.	See Remarks	Sale+OE	155	$1.29	$199.17	-4.2%	-51.9%	-92.3%
Apr 4, 2024	BTAI Bioxcel Therapeutics, Inc.	See Remarks	Sale+OE	165	$2.62	$432.48	-3.0%	-59.9%	-96.2%
Mar 15, 2023	BTAI Bioxcel Therapeutics, Inc.	Chief Medical Officer	Sale+OE	845	$19.70	$16,642.28	-40.5%	+2.8%	-85.4%
Jan 20, 2023	BTAI Bioxcel Therapeutics, Inc.	Chief Medical Officer	Sale+OE	29,713	$30.00	$891,390.00	-100%	-30.2%	-91.5%
Feb 17, 2021	BTAI Bioxcel Therapeutics, Inc.	Chief Medical Officer	Sale+OE	25,000	$55.58	$1,389,459.15	-33.1%	-	-
Jan 19, 2021	BTAI Bioxcel Therapeutics, Inc.	Chief Medical Officer	Sale+OE	25,000	$49.47	$1,236,719.14	-47.1%	-	-
Dec 28, 2020	BTAI Bioxcel Therapeutics, Inc.	Chief Medical Officer	Sale+OE	25,000	$51.45	$1,286,156.68	-58.6%	-	-